Table of Contents
2019-2024 Global Intravenous (IV) Ibuprofen Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous (IV) Ibuprofen Consumption 2014-2024
2.1.2 Intravenous (IV) Ibuprofen Consumption CAGR by Region
2.2 Intravenous (IV) Ibuprofen Segment by Type
2.2.1 100 mg Dose
2.2.2 200 mg Dose
2.2.3 400 mg Dose
2.2.4 800 mg Dose
2.3 Intravenous (IV) Ibuprofen Consumption by Type
2.3.1 Global Intravenous (IV) Ibuprofen Consumption Market Share by Type (2014-2019)
2.3.2 Global Intravenous (IV) Ibuprofen Revenue and Market Share by Type (2014-2019)
2.3.3 Global Intravenous (IV) Ibuprofen Sale Price by Type (2014-2019)
2.4 Intravenous (IV) Ibuprofen Segment by Application
2.4.1 Pain
2.4.2 Fever
2.4.3 Inflammation
2.5 Intravenous (IV) Ibuprofen Consumption by Application
2.5.1 Global Intravenous (IV) Ibuprofen Consumption Market Share by Application (2014-2019)
2.5.2 Global Intravenous (IV) Ibuprofen Value and Market Share by Application (2014-2019)
2.5.3 Global Intravenous (IV) Ibuprofen Sale Price by Application (2014-2019)
3 Global Intravenous (IV) Ibuprofen by Players
3.1 Global Intravenous (IV) Ibuprofen Sales Market Share by Players
3.1.1 Global Intravenous (IV) Ibuprofen Sales by Players (2017-2019)
3.1.2 Global Intravenous (IV) Ibuprofen Sales Market Share by Players (2017-2019)
3.2 Global Intravenous (IV) Ibuprofen Revenue Market Share by Players
3.2.1 Global Intravenous (IV) Ibuprofen Revenue by Players (2017-2019)
3.2.2 Global Intravenous (IV) Ibuprofen Revenue Market Share by Players (2017-2019)
3.3 Global Intravenous (IV) Ibuprofen Sale Price by Players
3.4 Global Intravenous (IV) Ibuprofen Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Intravenous (IV) Ibuprofen Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Intravenous (IV) Ibuprofen Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers and Acquisitions, Expansion
4 Intravenous (IV) Ibuprofen by Regions
4.1 Intravenous (IV) Ibuprofen by Regions
4.1.1 Global Intravenous (IV) Ibuprofen Consumption by Regions
4.1.2 Global Intravenous (IV) Ibuprofen Value by Regions
4.2 Americas Intravenous (IV) Ibuprofen Consumption Growth
4.3 APAC Intravenous (IV) Ibuprofen Consumption Growth
4.4 Europe Intravenous (IV) Ibuprofen Consumption Growth
4.5 Middle East and Africa Intravenous (IV) Ibuprofen Consumption Growth
5 Americas
5.1 Americas Intravenous (IV) Ibuprofen Consumption by Countries
5.1.1 Americas Intravenous (IV) Ibuprofen Consumption by Countries (2014-2019)
5.1.2 Americas Intravenous (IV) Ibuprofen Value by Countries (2014-2019)
5.2 Americas Intravenous (IV) Ibuprofen Consumption by Type
5.3 Americas Intravenous (IV) Ibuprofen Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Intravenous (IV) Ibuprofen Consumption by Countries
6.1.1 APAC Intravenous (IV) Ibuprofen Consumption by Countries (2014-2019)
6.1.2 APAC Intravenous (IV) Ibuprofen Value by Countries (2014-2019)
6.2 APAC Intravenous (IV) Ibuprofen Consumption by Type
6.3 APAC Intravenous (IV) Ibuprofen Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Intravenous (IV) Ibuprofen by Countries
7.1.1 Europe Intravenous (IV) Ibuprofen Consumption by Countries (2014-2019)
7.1.2 Europe Intravenous (IV) Ibuprofen Value by Countries (2014-2019)
7.2 Europe Intravenous (IV) Ibuprofen Consumption by Type
7.3 Europe Intravenous (IV) Ibuprofen Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East and Africa
8.1 Middle East and Africa Intravenous (IV) Ibuprofen by Countries
8.1.1 Middle East and Africa Intravenous (IV) Ibuprofen Consumption by Countries (2014-2019)
8.1.2 Middle East and Africa Intravenous (IV) Ibuprofen Value by Countries (2014-2019)
8.2 Middle East and Africa Intravenous (IV) Ibuprofen Consumption by Type
8.3 Middle East and Africa Intravenous (IV) Ibuprofen Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Intravenous (IV) Ibuprofen Distributors
10.3 Intravenous (IV) Ibuprofen Customer
11 Global Intravenous (IV) Ibuprofen Market Forecast
11.1 Global Intravenous (IV) Ibuprofen Consumption Forecast (2019-2024)
11.2 Global Intravenous (IV) Ibuprofen Forecast by Regions
11.2.1 Global Intravenous (IV) Ibuprofen Forecast by Regions (2019-2024)
11.2.2 Global Intravenous (IV) Ibuprofen Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East and Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East and Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Intravenous (IV) Ibuprofen Forecast by Type
11.8 Global Intravenous (IV) Ibuprofen Forecast by Application
12 Key Players Analysis
12.1 Cumberland Pharmaceuticals
12.1.1 Company Details
12.1.2 Intravenous (IV) Ibuprofen Product Offered
12.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Cumberland Pharmaceuticals News
12.2 Alveda Pharmaceuticals
12.2.1 Company Details
12.2.2 Intravenous (IV) Ibuprofen Product Offered
12.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Alveda Pharmaceuticals News
12.3 CSL Limited
12.3.1 Company Details
12.3.2 Intravenous (IV) Ibuprofen Product Offered
12.3.3 CSL Limited Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 CSL Limited News
12.4 Sandor Medicaids
12.4.1 Company Details
12.4.2 Intravenous (IV) Ibuprofen Product Offered
12.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Sandor Medicaids News
12.5 PT. Soho Industri Pharmasi
12.5.1 Company Details
12.5.2 Intravenous (IV) Ibuprofen Product Offered
12.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 PT. Soho Industri Pharmasi News
12.6 Germin MED
12.6.1 Company Details
12.6.2 Intravenous (IV) Ibuprofen Product Offered
12.6.3 Germin MED Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Germin MED News
12.7 Grifols
12.7.1 Company Details
12.7.2 Intravenous (IV) Ibuprofen Product Offered
12.7.3 Grifols Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Grifols News
12.8 Gloria Pharmaceuticals
12.8.1 Company Details
12.8.2 Intravenous (IV) Ibuprofen Product Offered
12.8.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Gloria Pharmaceuticals News
12.9 Al Nabeel International
12.9.1 Company Details
12.9.2 Intravenous (IV) Ibuprofen Product Offered
12.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Al Nabeel International News
12.10 Laboratorios Valmorca
12.10.1 Company Details
12.10.2 Intravenous (IV) Ibuprofen Product Offered
12.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Laboratorios Valmorca News
13 Research Findings and Conclusion
